Eli Lilly’s combination antibody therapy for COVID-19 cuts risk of hospitalization and death by 87%
The closest thing to a COVID ‘cure’? Eli Lilly’s combination antibody drug cuts the risk of COVID-19 hospitalization and death by 87%, study finds The combination treatment, a mixture of two drugs, recognizes the coronavirus and attaches to it, preventing it from spreading throughout the body Half a group of 769 mild-to-moderate COVID-19 patients at … Read more